The presence of the ryanodine receptor was recently demonstrated in vascular and endocardial endothelium, but its function has not been established. We investigated whether functional ryanodine-sensitive Ca2+ stores are present in cultured endothelial cells from rat aorta (RAECs), human aorta (HAECs), human umbilical vein (HUVECs), and bovine pulmonary artery (BPAECs) 
The presence of the ryanodine receptor was recently demonstrated in vascular and endocardial endothelium, but its function has not been established. We investigated whether functional ryanodine-sensitive Ca2+ stores are present in cultured endothelial cells from rat aorta (RAECs), human aorta (HAECs), human umbilical vein (HUVECs), and bovine pulmonary artery (BPAECs) and what role these may play in intracellular Ca 2+ regulation. Under resting conditions, HAECs, BPAECs, and HUVECs demonstrated a slow increase in intracellular Ca2+ (indexed by indo 1 fluorescence) on exposure to 5 gmol/L ryanodine, whereas RAECs did not.
However, after an initial bradykinin exposure in RAECs, ryanodine markedly blunted the rapid increase in Ca2' on a A increase in [Ca2+] is important in mediating many of the functional properties of vascular endothelial cells, particularly release of vasodilatory prostaglandins',2 and endothelium-derived relaxation factor.3 Inositol 1,4,5-trisphosphate (InsP3)-mediated release of Ca21 from intracellular stores appears largely responsible for the rapid transient increase in cytosolic Ca21 that occurs on agonist stimulation. [4] [5] [6] [7] [8] [9] [10] [11] [12] Although considerable information has been learned about endothelial Ca2' regulation, the identity and sensitivity of the intracellular compartments are not completely known. Further identification of these intracellular stores is facilitated by the use of appropriate pharmacologic probes.
The plant alkaloid ryanodine has been used to study
[Ca 2ji regulation in striated muscle.13-15Ryanodine is known to bind to the Ca2' release channels of the sarcoplasmic reticulum1617 and to thereby alter its Ca2' release properties. At The effects of ryanodine in vascular endothelial cells appear to vary with species, the vascular bed of origin of the cell type, or both. This is similar to the variation in the effect of ryanodine on inhibition of the twitch in cardiac muscle preparations from different species. [31] [32] [33] [34] Although the etiology of this species variation for both vascular endothelium and cardiac muscle is unknown, it may relate to a species difference in the extent of endoplasmic or sarcoplasmic reticulum loading. Alternatively, it may relate to differences in membrane permeability to ryanodine. Our results also indicate some variability even within a given cell type.
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